Role of peroxisome proliferator-activated receptor γ and retinoid X receptor heterodimer in hepatogastroenterological diseases

This publication has 85 references indexed in Scilit:

• Diabetic KKAy mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
  Published by Elsevier ,2001
• Involvement of P21Waf1/Cip1, P27Kip1, and P18Ink4c in Troglitazone–Induced Cell–Cycle Arrest in Human Hepatoma Cell Lines
  Hepatology, 2001
• Expression of Retinoid Receptors during Human Monocyte Differentiation in Vitro
  Biochemical and Biophysical Research Communications, 2000
• Evidence for the Presence of Peroxisome Proliferator-activated Receptor (PPAR) α and γ and Retinoid Z Receptor in Cartilage
  Journal of Biological Chemistry, 2000
• Monocyte Chemotactic Protein–1 As A Chemoattractant for Human Hepatic Stellate Cells
  Hepatology, 1999
• Increased Expression of Cyclooxygenases and Peroxisome Proliferator-Activated Receptor-γ in Alzheimer's Disease Brains
  Biochemical and Biophysical Research Communications, 1999
• PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
  FEBS Letters, 1998
• The peroxisome proliferator activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
• The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
  New England Journal of Medicine, 1993
• 9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
  Nature, 1992